Search - tctmd.com

Displaying 921 - 940 of 2033

Sort: Relevancy | Date

News Industry News

New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints

May 12, 2017

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

May 11, 2017

News Industry News

Boston Scientific Receives U.S. FDA Approval For Resonate™ Family Of High-Voltage Devices

May 09, 2017

News Industry News

Abbott Announces CE Mark For Tacticath Contact Force Ablation Catheter, Sensor Enabled

May 09, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Industry News

Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor

May 08, 2017

News Industry News

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

May 05, 2017

News Features

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

Shelley Wood

May 05, 2017

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

May 02, 2017

News Industry News

LivaNova Acquires Caisson Interventional, LLC

May 02, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2017

Shelley Wood

April 28, 2017

News Industry News

NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation

April 26, 2017

News Daily News

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Michael O'Riordan

April 18, 2017

News Daily News

Rapid Rule-Out Strategy With High-Sensitivity Troponin Shows Promise Ahead of US Commercial Availability of Test

L.A. McKeown

April 17, 2017

Presentation

Rapid Rule Out of Acute MI With Single High-Sensitivity Cardiac Troponin T Below Limit of Detection

April 17, 2017

News Daily News

Absorb BVS Use Restricted in Europe

Michael O'Riordan

April 06, 2017

News Daily News

Looking Beyond Randomized Trials: Could a Wider Range of Studies Support Device Approval?

Todd Neale

April 05, 2017

News Industry News

REVA Receives CE Mark for Fantom

April 04, 2017

News Daily News

Boston Scientific Adds Two More TAVR Valves With Symetis Purchase

Michael O'Riordan

March 30, 2017

News Industry News

REVA to Expand FANTOM II Trial to More Complex Cases

March 24, 2017

Advertisement

New Data from PLATINUM Diversity Study Presented at SCAI 2017 Provide Important Insights Beyond Traditional Clinically-Reported Endpoints

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

Boston Scientific Receives U.S. FDA Approval For Resonate™ Family Of High-Voltage Devices

Abbott Announces CE Mark For Tacticath Contact Force Ablation Catheter, Sensor Enabled

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor

Abiomed Announces First Patient Enrolled in STEMI DTU Feasibility Study

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes

LivaNova Acquires Caisson Interventional, LLC

TCTMD’s Top 10 Most Popular Stories for April 2017

NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation

Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance

Rapid Rule-Out Strategy With High-Sensitivity Troponin Shows Promise Ahead of US Commercial Availability of Test

Rapid Rule Out of Acute MI With Single High-Sensitivity Cardiac Troponin T Below Limit of Detection

Absorb BVS Use Restricted in Europe

Looking Beyond Randomized Trials: Could a Wider Range of Studies Support Device Approval?

REVA Receives CE Mark for Fantom

Boston Scientific Adds Two More TAVR Valves With Symetis Purchase

REVA to Expand FANTOM II Trial to More Complex Cases

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content